RSS Free Biotechnology & Pharmaceuticals Magazines

  • The State of Drug Pricing Reform in 2023
    Drug pricing reform in the U.S. is both further along than it’s been in years and stuck facing the same long odds that have frustrated past attempts at a major federal overhaul. If recent actions from Congress and the White House are any indication, pricing looks set to remain pharma’s greatest reputational risk of 2023 […]